Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of booster
- 10 March 2000
- Vol. 18 (21) , 2295-2306
- https://doi.org/10.1016/s0264-410x(99)00539-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccineThe Lancet, 1997
- Diphtheria immunity in flandersEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Diphtheria Antitoxin Levels in US Blood and Plasma DonorsThe Journal of Infectious Diseases, 1996
- Absence of protective immunity against diphtheria in a large proportion of young adultsVaccine, 1993
- Diphtheria, pertussis, and tetanus vaccinationThe Lancet, 1992
- Improvement of a Vero cell assay to determine diphtheria antitoxin content in seraBiologicals, 1991
- Evaluation of a New Highly Purified Pertussis Vaccine in Infants and ChildrenThe Journal of Infectious Diseases, 1989
- Immunity and immunization of children against diphtheria in SwedenEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Diphtheria Outbreaks in Immunized PopulationsNew England Journal of Medicine, 1988
- ANTITOXIN CURVE IN CHILDREN AFTER ACTIVE IMMUNIZATION WITH DIPHTHERIA ANATOXIN with special reference to the DURATION OF THE ANTITOXIC IMMUNITY1Acta Pathologica Microbiologica Scandinavica, 1933